The global Pain Therapeutic Injection market was valued at US$ 19300 million in 2023 and is anticipated to reach US$ 26240 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.

Pain Therapeutic Injection Market

Pain Therapeutic Injectable is administered directly into the joint, where they are formulated to reduce inflammation and pain. Once injected into the joint, pain relief is almost immediate.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pain Therapeutic Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Therapeutic Injection.

Report Scope

The Pain Therapeutic Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Therapeutic Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pain Therapeutic Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pain Therapeutic Injection Market Report

Report Metric	Details
Report Name	Pain Therapeutic Injection Market
Accounted market size in 2023	US$ 19300 million
Forecasted market size in 2030	US$ 26240 million
CAGR	4.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	OTC Drugs Prescription Drugs
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AbbVie Inc., Bristol Myers Squibb Co., Sanofi S.A., Boehringer Ingelheim International GmbH, Pfizer Inc., Zydus Lifesciences Ltd., GSK plc., Abbott Laboratories, Inc., Novartis AG, Johnson & Johnson, Teva Pharmaceuticals Ltd., Mallinckrodt Pharmaceuticals, Bayer AG, F. Hoffmann-La Roche Ltd., AstraZeneca, Cardinal Health, Perrigo Company Plc., Bausch Health Companies Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pain Therapeutic Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pain Therapeutic Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pain Therapeutic Injection Market growing?

Ans: The Pain Therapeutic Injection Market witnessing a CAGR of 4.5% during the forecast period 2024-2030.

What is the Pain Therapeutic Injection Market size in 2030?

Ans: The Pain Therapeutic Injection Market size in 2030 will be US$ 26240 million.

Who are the main players in the Pain Therapeutic Injection Market report?

Ans: The main players in the Pain Therapeutic Injection Market are AbbVie Inc., Bristol Myers Squibb Co., Sanofi S.A., Boehringer Ingelheim International GmbH, Pfizer Inc., Zydus Lifesciences Ltd., GSK plc., Abbott Laboratories, Inc., Novartis AG, Johnson & Johnson, Teva Pharmaceuticals Ltd., Mallinckrodt Pharmaceuticals, Bayer AG, F. Hoffmann-La Roche Ltd., AstraZeneca, Cardinal Health, Perrigo Company Plc., Bausch Health Companies Inc.

What are the Application segmentation covered in the Pain Therapeutic Injection Market report?

Ans: The Applications covered in the Pain Therapeutic Injection Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Pain Therapeutic Injection Market report?

Ans: The Types covered in the Pain Therapeutic Injection Market report are OTC Drugs, Prescription Drugs

1 Pain Therapeutic Injection Market Overview

1.1 Product Overview and Scope of Pain Therapeutic Injection

1.2 Pain Therapeutic Injection Segment by Type

1.2.1 Global Pain Therapeutic Injection Market Value Comparison by Type (2024-2030)

1.2.2 OTC Drugs

1.2.3 Prescription Drugs

1.3 Pain Therapeutic Injection Segment by Application

1.3.1 Global Pain Therapeutic Injection Market Value by Application: (2024-2030)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Pain Therapeutic Injection Market Size Estimates and Forecasts

1.4.1 Global Pain Therapeutic Injection Revenue 2019-2030

1.4.2 Global Pain Therapeutic Injection Sales 2019-2030

1.4.3 Global Pain Therapeutic Injection Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Pain Therapeutic Injection Market Competition by Manufacturers

2.1 Global Pain Therapeutic Injection Sales Market Share by Manufacturers (2019-2024)

2.2 Global Pain Therapeutic Injection Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Pain Therapeutic Injection Average Price by Manufacturers (2019-2024)

2.4 Global Pain Therapeutic Injection Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pain Therapeutic Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pain Therapeutic Injection, Product Type & Application

2.7 Pain Therapeutic Injection Market Competitive Situation and Trends

2.7.1 Pain Therapeutic Injection Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Pain Therapeutic Injection Players Market Share by Revenue

2.7.3 Global Pain Therapeutic Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pain Therapeutic Injection Retrospective Market Scenario by Region

3.1 Global Pain Therapeutic Injection Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Pain Therapeutic Injection Global Pain Therapeutic Injection Sales by Region: 2019-2030

3.2.1 Global Pain Therapeutic Injection Sales by Region: 2019-2024

3.2.2 Global Pain Therapeutic Injection Sales by Region: 2025-2030

3.3 Global Pain Therapeutic Injection Global Pain Therapeutic Injection Revenue by Region: 2019-2030

3.3.1 Global Pain Therapeutic Injection Revenue by Region: 2019-2024

3.3.2 Global Pain Therapeutic Injection Revenue by Region: 2025-2030

3.4 North America Pain Therapeutic Injection Market Facts & Figures by Country

3.4.1 North America Pain Therapeutic Injection Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Pain Therapeutic Injection Sales by Country (2019-2030)

3.4.3 North America Pain Therapeutic Injection Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pain Therapeutic Injection Market Facts & Figures by Country

3.5.1 Europe Pain Therapeutic Injection Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Pain Therapeutic Injection Sales by Country (2019-2030)

3.5.3 Europe Pain Therapeutic Injection Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pain Therapeutic Injection Market Facts & Figures by Country

3.6.1 Asia Pacific Pain Therapeutic Injection Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Pain Therapeutic Injection Sales by Country (2019-2030)

3.6.3 Asia Pacific Pain Therapeutic Injection Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pain Therapeutic Injection Market Facts & Figures by Country

3.7.1 Latin America Pain Therapeutic Injection Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Pain Therapeutic Injection Sales by Country (2019-2030)

3.7.3 Latin America Pain Therapeutic Injection Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pain Therapeutic Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Pain Therapeutic Injection Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Pain Therapeutic Injection Sales by Country (2019-2030)

3.8.3 Middle East and Africa Pain Therapeutic Injection Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pain Therapeutic Injection Sales by Type (2019-2030)

4.1.1 Global Pain Therapeutic Injection Sales by Type (2019-2024)

4.1.2 Global Pain Therapeutic Injection Sales by Type (2025-2030)

4.1.3 Global Pain Therapeutic Injection Sales Market Share by Type (2019-2030)

4.2 Global Pain Therapeutic Injection Revenue by Type (2019-2030)

4.2.1 Global Pain Therapeutic Injection Revenue by Type (2019-2024)

4.2.2 Global Pain Therapeutic Injection Revenue by Type (2025-2030)

4.2.3 Global Pain Therapeutic Injection Revenue Market Share by Type (2019-2030)

4.3 Global Pain Therapeutic Injection Price by Type (2019-2030)

5 Segment by Application

5.1 Global Pain Therapeutic Injection Sales by Application (2019-2030)

5.1.1 Global Pain Therapeutic Injection Sales by Application (2019-2024)

5.1.2 Global Pain Therapeutic Injection Sales by Application (2025-2030)

5.1.3 Global Pain Therapeutic Injection Sales Market Share by Application (2019-2030)

5.2 Global Pain Therapeutic Injection Revenue by Application (2019-2030)

5.2.1 Global Pain Therapeutic Injection Revenue by Application (2019-2024)

5.2.2 Global Pain Therapeutic Injection Revenue by Application (2025-2030)

5.2.3 Global Pain Therapeutic Injection Revenue Market Share by Application (2019-2030)

5.3 Global Pain Therapeutic Injection Price by Application (2019-2030)

6 Key Companies Profiled

6.1 AbbVie Inc.

6.1.1 AbbVie Inc. Corporation Information

6.1.2 AbbVie Inc. Description and Business Overview

6.1.3 AbbVie Inc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.1.4 AbbVie Inc. Pain Therapeutic Injection Product Portfolio

6.1.5 AbbVie Inc. Recent Developments/Updates

6.2 Bristol Myers Squibb Co.

6.2.1 Bristol Myers Squibb Co. Corporation Information

6.2.2 Bristol Myers Squibb Co. Description and Business Overview

6.2.3 Bristol Myers Squibb Co. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Bristol Myers Squibb Co. Pain Therapeutic Injection Product Portfolio

6.2.5 Bristol Myers Squibb Co. Recent Developments/Updates

6.3 Sanofi S.A.

6.3.1 Sanofi S.A. Corporation Information

6.3.2 Sanofi S.A. Description and Business Overview

6.3.3 Sanofi S.A. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi S.A. Pain Therapeutic Injection Product Portfolio

6.3.5 Sanofi S.A. Recent Developments/Updates

6.4 Boehringer Ingelheim International GmbH

6.4.1 Boehringer Ingelheim International GmbH Corporation Information

6.4.2 Boehringer Ingelheim International GmbH Description and Business Overview

6.4.3 Boehringer Ingelheim International GmbH Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Boehringer Ingelheim International GmbH Pain Therapeutic Injection Product Portfolio

6.4.5 Boehringer Ingelheim International GmbH Recent Developments/Updates

6.5 Pfizer Inc.

6.5.1 Pfizer Inc. Corporation Information

6.5.2 Pfizer Inc. Description and Business Overview

6.5.3 Pfizer Inc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Pfizer Inc. Pain Therapeutic Injection Product Portfolio

6.5.5 Pfizer Inc. Recent Developments/Updates

6.6 Zydus Lifesciences Ltd.

6.6.1 Zydus Lifesciences Ltd. Corporation Information

6.6.2 Zydus Lifesciences Ltd. Description and Business Overview

6.6.3 Zydus Lifesciences Ltd. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Zydus Lifesciences Ltd. Pain Therapeutic Injection Product Portfolio

6.6.5 Zydus Lifesciences Ltd. Recent Developments/Updates

6.7 GSK plc.

6.6.1 GSK plc. Corporation Information

6.6.2 GSK plc. Description and Business Overview

6.6.3 GSK plc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GSK plc. Pain Therapeutic Injection Product Portfolio

6.7.5 GSK plc. Recent Developments/Updates

6.8 Abbott Laboratories, Inc.

6.8.1 Abbott Laboratories, Inc. Corporation Information

6.8.2 Abbott Laboratories, Inc. Description and Business Overview

6.8.3 Abbott Laboratories, Inc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Abbott Laboratories, Inc. Pain Therapeutic Injection Product Portfolio

6.8.5 Abbott Laboratories, Inc. Recent Developments/Updates

6.9 Novartis AG

6.9.1 Novartis AG Corporation Information

6.9.2 Novartis AG Description and Business Overview

6.9.3 Novartis AG Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Novartis AG Pain Therapeutic Injection Product Portfolio

6.9.5 Novartis AG Recent Developments/Updates

6.10 Johnson & Johnson

6.10.1 Johnson & Johnson Corporation Information

6.10.2 Johnson & Johnson Description and Business Overview

6.10.3 Johnson & Johnson Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Johnson & Johnson Pain Therapeutic Injection Product Portfolio

6.10.5 Johnson & Johnson Recent Developments/Updates

6.11 Teva Pharmaceuticals Ltd.

6.11.1 Teva Pharmaceuticals Ltd. Corporation Information

6.11.2 Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Description and Business Overview

6.11.3 Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Product Portfolio

6.11.5 Teva Pharmaceuticals Ltd. Recent Developments/Updates

6.12 Mallinckrodt Pharmaceuticals

6.12.1 Mallinckrodt Pharmaceuticals Corporation Information

6.12.2 Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Description and Business Overview

6.12.3 Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Product Portfolio

6.12.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates

6.13 Bayer AG

6.13.1 Bayer AG Corporation Information

6.13.2 Bayer AG Pain Therapeutic Injection Description and Business Overview

6.13.3 Bayer AG Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Bayer AG Pain Therapeutic Injection Product Portfolio

6.13.5 Bayer AG Recent Developments/Updates

6.14 F. Hoffmann-La Roche Ltd.

6.14.1 F. Hoffmann-La Roche Ltd. Corporation Information

6.14.2 F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Description and Business Overview

6.14.3 F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.14.4 F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Product Portfolio

6.14.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates

6.15 AstraZeneca

6.15.1 AstraZeneca Corporation Information

6.15.2 AstraZeneca Pain Therapeutic Injection Description and Business Overview

6.15.3 AstraZeneca Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.15.4 AstraZeneca Pain Therapeutic Injection Product Portfolio

6.15.5 AstraZeneca Recent Developments/Updates

6.16 Cardinal Health

6.16.1 Cardinal Health Corporation Information

6.16.2 Cardinal Health Pain Therapeutic Injection Description and Business Overview

6.16.3 Cardinal Health Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Cardinal Health Pain Therapeutic Injection Product Portfolio

6.16.5 Cardinal Health Recent Developments/Updates

6.17 Perrigo Company Plc.

6.17.1 Perrigo Company Plc. Corporation Information

6.17.2 Perrigo Company Plc. Pain Therapeutic Injection Description and Business Overview

6.17.3 Perrigo Company Plc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Perrigo Company Plc. Pain Therapeutic Injection Product Portfolio

6.17.5 Perrigo Company Plc. Recent Developments/Updates

6.18 Bausch Health Companies Inc.

6.18.1 Bausch Health Companies Inc. Corporation Information

6.18.2 Bausch Health Companies Inc. Pain Therapeutic Injection Description and Business Overview

6.18.3 Bausch Health Companies Inc. Pain Therapeutic Injection Sales, Revenue and Gross Margin (2019-2024)

6.18.4 Bausch Health Companies Inc. Pain Therapeutic Injection Product Portfolio

6.18.5 Bausch Health Companies Inc. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pain Therapeutic Injection Industry Chain Analysis

7.2 Pain Therapeutic Injection Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pain Therapeutic Injection Production Mode & Process

7.4 Pain Therapeutic Injection Sales and Marketing

7.4.1 Pain Therapeutic Injection Sales Channels

7.4.2 Pain Therapeutic Injection Distributors

7.5 Pain Therapeutic Injection Customers

8 Pain Therapeutic Injection Market Dynamics

8.1 Pain Therapeutic Injection Industry Trends

8.2 Pain Therapeutic Injection Market Drivers

8.3 Pain Therapeutic Injection Market Challenges

8.4 Pain Therapeutic Injection Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

AbbVie

Bristol-Myers Squibb Co

Sanofi

Boehringer Ingelheim International GmbH

Pfizer Inc

Zydus Lifesciences Ltd

GSK

Abbott Laboratories Inc

Novartis

Johnson & Johnson

Teva Pharmaceuticals Ltd.

Mallinckrodt Pharmaceuticals

Bayer

F Hoffmann La Roche Ltd

Astrazeneca plc

Cardinal Health

Perrigo Company plc

Bausch Health Companies Inc.

List of Tables

Table 1. Global Pain Therapeutic Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Pain Therapeutic Injection Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Pain Therapeutic Injection Market Competitive Situation by Manufacturers in 2023

Table 4. Global Pain Therapeutic Injection Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Pain Therapeutic Injection Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Pain Therapeutic Injection Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Pain Therapeutic Injection Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Pain Therapeutic Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Pain Therapeutic Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pain Therapeutic Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pain Therapeutic Injection, Product Type & Application

Table 12. Global Key Manufacturers of Pain Therapeutic Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pain Therapeutic Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Therapeutic Injection as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pain Therapeutic Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Pain Therapeutic Injection Sales by Region (2019-2024) & (K Units)

Table 18. Global Pain Therapeutic Injection Sales Market Share by Region (2019-2024)

Table 19. Global Pain Therapeutic Injection Sales by Region (2025-2030) & (K Units)

Table 20. Global Pain Therapeutic Injection Sales Market Share by Region (2025-2030)

Table 21. Global Pain Therapeutic Injection Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Pain Therapeutic Injection Revenue Market Share by Region (2019-2024)

Table 23. Global Pain Therapeutic Injection Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Pain Therapeutic Injection Revenue Market Share by Region (2025-2030)

Table 25. North America Pain Therapeutic Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Pain Therapeutic Injection Sales by Country (2019-2024) & (K Units)

Table 27. North America Pain Therapeutic Injection Sales by Country (2025-2030) & (K Units)

Table 28. North America Pain Therapeutic Injection Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Pain Therapeutic Injection Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Pain Therapeutic Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Pain Therapeutic Injection Sales by Country (2019-2024) & (K Units)

Table 32. Europe Pain Therapeutic Injection Sales by Country (2025-2030) & (K Units)

Table 33. Europe Pain Therapeutic Injection Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Pain Therapeutic Injection Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Pain Therapeutic Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Pain Therapeutic Injection Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Pain Therapeutic Injection Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Pain Therapeutic Injection Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Pain Therapeutic Injection Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pain Therapeutic Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Pain Therapeutic Injection Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Pain Therapeutic Injection Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Pain Therapeutic Injection Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Pain Therapeutic Injection Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Pain Therapeutic Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Pain Therapeutic Injection Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Pain Therapeutic Injection Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Pain Therapeutic Injection Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Pain Therapeutic Injection Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Pain Therapeutic Injection Sales (K Units) by Type (2019-2024)

Table 51. Global Pain Therapeutic Injection Sales (K Units) by Type (2025-2030)

Table 52. Global Pain Therapeutic Injection Sales Market Share by Type (2019-2024)

Table 53. Global Pain Therapeutic Injection Sales Market Share by Type (2025-2030)

Table 54. Global Pain Therapeutic Injection Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Pain Therapeutic Injection Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Pain Therapeutic Injection Revenue Market Share by Type (2019-2024)

Table 57. Global Pain Therapeutic Injection Revenue Market Share by Type (2025-2030)

Table 58. Global Pain Therapeutic Injection Price (US$/Unit) by Type (2019-2024)

Table 59. Global Pain Therapeutic Injection Price (US$/Unit) by Type (2025-2030)

Table 60. Global Pain Therapeutic Injection Sales (K Units) by Application (2019-2024)

Table 61. Global Pain Therapeutic Injection Sales (K Units) by Application (2025-2030)

Table 62. Global Pain Therapeutic Injection Sales Market Share by Application (2019-2024)

Table 63. Global Pain Therapeutic Injection Sales Market Share by Application (2025-2030)

Table 64. Global Pain Therapeutic Injection Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Pain Therapeutic Injection Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Pain Therapeutic Injection Revenue Market Share by Application (2019-2024)

Table 67. Global Pain Therapeutic Injection Revenue Market Share by Application (2025-2030)

Table 68. Global Pain Therapeutic Injection Price (US$/Unit) by Application (2019-2024)

Table 69. Global Pain Therapeutic Injection Price (US$/Unit) by Application (2025-2030)

Table 70. AbbVie Inc. Corporation Information

Table 71. AbbVie Inc. Description and Business Overview

Table 72. AbbVie Inc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. AbbVie Inc. Pain Therapeutic Injection Product

Table 74. AbbVie Inc. Recent Developments/Updates

Table 75. Bristol Myers Squibb Co. Corporation Information

Table 76. Bristol Myers Squibb Co. Description and Business Overview

Table 77. Bristol Myers Squibb Co. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Bristol Myers Squibb Co. Pain Therapeutic Injection Product

Table 79. Bristol Myers Squibb Co. Recent Developments/Updates

Table 80. Sanofi S.A. Corporation Information

Table 81. Sanofi S.A. Description and Business Overview

Table 82. Sanofi S.A. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Sanofi S.A. Pain Therapeutic Injection Product

Table 84. Sanofi S.A. Recent Developments/Updates

Table 85. Boehringer Ingelheim International GmbH Corporation Information

Table 86. Boehringer Ingelheim International GmbH Description and Business Overview

Table 87. Boehringer Ingelheim International GmbH Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Boehringer Ingelheim International GmbH Pain Therapeutic Injection Product

Table 89. Boehringer Ingelheim International GmbH Recent Developments/Updates

Table 90. Pfizer Inc. Corporation Information

Table 91. Pfizer Inc. Description and Business Overview

Table 92. Pfizer Inc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Pfizer Inc. Pain Therapeutic Injection Product

Table 94. Pfizer Inc. Recent Developments/Updates

Table 95. Zydus Lifesciences Ltd. Corporation Information

Table 96. Zydus Lifesciences Ltd. Description and Business Overview

Table 97. Zydus Lifesciences Ltd. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Zydus Lifesciences Ltd. Pain Therapeutic Injection Product

Table 99. Zydus Lifesciences Ltd. Recent Developments/Updates

Table 100. GSK plc. Corporation Information

Table 101. GSK plc. Description and Business Overview

Table 102. GSK plc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. GSK plc. Pain Therapeutic Injection Product

Table 104. GSK plc. Recent Developments/Updates

Table 105. Abbott Laboratories, Inc. Corporation Information

Table 106. Abbott Laboratories, Inc. Description and Business Overview

Table 107. Abbott Laboratories, Inc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Abbott Laboratories, Inc. Pain Therapeutic Injection Product

Table 109. Abbott Laboratories, Inc. Recent Developments/Updates

Table 110. Novartis AG Corporation Information

Table 111. Novartis AG Description and Business Overview

Table 112. Novartis AG Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Novartis AG Pain Therapeutic Injection Product

Table 114. Novartis AG Recent Developments/Updates

Table 115. Johnson & Johnson Corporation Information

Table 116. Johnson & Johnson Description and Business Overview

Table 117. Johnson & Johnson Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Johnson & Johnson Pain Therapeutic Injection Product

Table 119. Johnson & Johnson Recent Developments/Updates

Table 120. Teva Pharmaceuticals Ltd. Corporation Information

Table 121. Teva Pharmaceuticals Ltd. Description and Business Overview

Table 122. Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Teva Pharmaceuticals Ltd. Pain Therapeutic Injection Product

Table 124. Teva Pharmaceuticals Ltd. Recent Developments/Updates

Table 125. Mallinckrodt Pharmaceuticals Corporation Information

Table 126. Mallinckrodt Pharmaceuticals Description and Business Overview

Table 127. Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Mallinckrodt Pharmaceuticals Pain Therapeutic Injection Product

Table 129. Mallinckrodt Pharmaceuticals Recent Developments/Updates

Table 130. Bayer AG Corporation Information

Table 131. Bayer AG Description and Business Overview

Table 132. Bayer AG Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Bayer AG Pain Therapeutic Injection Product

Table 134. Bayer AG Recent Developments/Updates

Table 135. F. Hoffmann-La Roche Ltd. Corporation Information

Table 136. F. Hoffmann-La Roche Ltd. Description and Business Overview

Table 137. F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. F. Hoffmann-La Roche Ltd. Pain Therapeutic Injection Product

Table 139. F. Hoffmann-La Roche Ltd. Recent Developments/Updates

Table 140. AstraZeneca Corporation Information

Table 141. AstraZeneca Description and Business Overview

Table 142. AstraZeneca Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. AstraZeneca Pain Therapeutic Injection Product

Table 144. AstraZeneca Recent Developments/Updates

Table 145. Cardinal Health Corporation Information

Table 146. Cardinal Health Description and Business Overview

Table 147. Cardinal Health Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Cardinal Health Pain Therapeutic Injection Product

Table 149. Cardinal Health Recent Developments/Updates

Table 150. Perrigo Company Plc. Corporation Information

Table 151. Perrigo Company Plc. Description and Business Overview

Table 152. Perrigo Company Plc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 153. Perrigo Company Plc. Pain Therapeutic Injection Product

Table 154. Perrigo Company Plc. Recent Developments/Updates

Table 155. Bausch Health Companies Inc. Corporation Information

Table 156. Bausch Health Companies Inc. Description and Business Overview

Table 157. Bausch Health Companies Inc. Pain Therapeutic Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 158. Bausch Health Companies Inc. Pain Therapeutic Injection Product

Table 159. Bausch Health Companies Inc. Recent Developments/Updates

Table 160. Key Raw Materials Lists

Table 161. Raw Materials Key Suppliers Lists

Table 162. Pain Therapeutic Injection Distributors List

Table 163. Pain Therapeutic Injection Customers List

Table 164. Pain Therapeutic Injection Market Trends

Table 165. Pain Therapeutic Injection Market Drivers

Table 166. Pain Therapeutic Injection Market Challenges

Table 167. Pain Therapeutic Injection Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Pain Therapeutic Injection

Figure 2. Global Pain Therapeutic Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Pain Therapeutic Injection Market Share by Type in 2023 & 2030

Figure 4. OTC Drugs Product Picture

Figure 5. Prescription Drugs Product Picture

Figure 6. Global Pain Therapeutic Injection Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Pain Therapeutic Injection Market Share by Application in 2023 & 2030

Figure 8. Hospital Pharmacies

Figure 9. Retail Pharmacies

Figure 10. Online Pharmacies

Figure 11. Global Pain Therapeutic Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Pain Therapeutic Injection Market Size (2019-2030) & (US$ Million)

Figure 13. Global Pain Therapeutic Injection Sales (2019-2030) & (K Units)

Figure 14. Global Pain Therapeutic Injection Average Price (US$/Unit) & (2019-2030)

Figure 15. Pain Therapeutic Injection Report Years Considered

Figure 16. Pain Therapeutic Injection Sales Share by Manufacturers in 2023

Figure 17. Global Pain Therapeutic Injection Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Pain Therapeutic Injection Players: Market Share by Revenue in 2023

Figure 19. Pain Therapeutic Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Pain Therapeutic Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Pain Therapeutic Injection Sales Market Share by Country (2019-2030)

Figure 22. North America Pain Therapeutic Injection Revenue Market Share by Country (2019-2030)

Figure 23. United States Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Pain Therapeutic Injection Sales Market Share by Country (2019-2030)

Figure 26. Europe Pain Therapeutic Injection Revenue Market Share by Country (2019-2030)

Figure 27. Germany Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Pain Therapeutic Injection Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Pain Therapeutic Injection Revenue Market Share by Region (2019-2030)

Figure 34. China Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Pain Therapeutic Injection Sales Market Share by Country (2019-2030)

Figure 42. Latin America Pain Therapeutic Injection Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Pain Therapeutic Injection Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Pain Therapeutic Injection Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Pain Therapeutic Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Pain Therapeutic Injection by Type (2019-2030)

Figure 52. Global Revenue Market Share of Pain Therapeutic Injection by Type (2019-2030)

Figure 53. Global Pain Therapeutic Injection Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Pain Therapeutic Injection by Application (2019-2030)

Figure 55. Global Revenue Market Share of Pain Therapeutic Injection by Application (2019-2030)

Figure 56. Global Pain Therapeutic Injection Price (US$/Unit) by Application (2019-2030)

Figure 57. Pain Therapeutic Injection Value Chain

Figure 58. Pain Therapeutic Injection Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions